MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$125,139K
Prepaid expenses and
other current assets
$3,022K
Accounts receivable
$1,115K
Total current assets
$129,276K
In-process research and
development assets
$93,900K
Goodwill
$48,163K
Property and equipment,
net
$12,185K
Right-of-use assets, net
$5,601K
Long-term prepaid
expenses and other assets
$5,551K
Long-term restricted cash
$1,735K
Total assets
$296,411K
Accumulated deficit
-$822,373K
Accumulated other
comprehensive loss
-$4,576K
Total liabilities and
stockholders deficit
$296,411K
Total stockholders
deficit
-$126,240K
Additional paid-in capital
$700,706K
Common stock, 0.0001
par value...
$3K
Total liabilities
$422,651K
Contingent value right
liability, net of current...
$392,100K
Total current
liabilities
$14,937K
Lease liabilities,
net of current...
$8,525K
Deferred tax
liabilities, net
$6,948K
Warrant liability
$141K
Accrued expenses and
other current...
$9,498K
Lease liabilities
$4,151K
Accounts payable
$1,288K
Back
Back
Balance Sheet
source: myfinsight.com
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)